Glaucoma: definitions, epidemiology and pathophysiology

21 February 2017
Volume 18, Issue 1

Glaucoma is a complex and broad subject and this group of diseases is commonly encountered by optometrists in their practice.

Introduction

The glaucomas are a group of diseases characterised by progressive loss of retinal ganglion cells. This results in cupping of the optic disc, development of progressive and permanent visual field defects and potentially total blindness at the end stage of the disease. Glaucoma is currently the second commonest cause of blindness worldwide after cataracts (Resnikoff et al. 2004). Globally it is predicted to affect approximately 80 million people by 2020 (Quigley and Broman 2006).

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

This is an in-person peer review taking place at Assembly Buildings, Belfast.

We have responded to the UK National Screening Committee's consultation on glaucoma.

Pressure on optometrists to treat glaucoma is likely to grow as case numbers are predicted to rise 44% by 2035. Beta blockers will remain a part of the fight ahead, as Adrian O’Dowd reports.